Development of these HGF SCID models was pivotal in the advancement of in vivo investigations of HGF/c-Met signaling enabling enhanced tumor growth of HGF-dependent cell lines and more translatable investigation of the pathway in HNSCC [125,126]. The gene discussed is MET; the disease is neoplasm.